SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 44,250
+2,850 (6.88%)
Mar 5, 2026, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 3.47 trillion as of March 5, 2026. Its market cap has decreased by -9.59% in one year.
Market Cap
3.47T
Enterprise Value
3.12T
Revenue
624.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
44,250.00
Market Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 3.47T, a decrease of -73.15%. That is a compound annual growth rate of -23.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 3.25T | -14.06% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | 12.93T | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 8.63T |
| HLB Co., Ltd. | 7.19T |
| LigaChem Biosciences | 7.00T |
| Peptron | 6.03T |
| Voronoi | 5.90T |
| OliX Pharmaceuticals | 3.92T |
| D&D Pharmatech | 3.70T |
| PharmaResearch | 3.41T |